Levemir
Pricing Report NDC 0169-6439-10

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Levemir (NDC 0169-6439-10) is $26.08463 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 22, 2016.

As a provided by Novo Nordisk, this medication is distributed in a 5 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$26.08463
Per ML

Effective Date
Jun 22, 2016
Data Status
As of Nov 30, 2016
C/I - Chain or Independent Pharmacy
Package NDC
Description
5 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2013, the NADAC wholesale price for (NDC ) has moved within a range of $18.02815 to $26.12949 per ML. Over this 2 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$18.0282 - $26.1295
Market Volatility
44.94% Variance
Latest Trend
0.17%
Date Unit Price Unit Source Method Rate
Jun 22, 2016 $26.08463 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 22, 2016 $26.08463 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Aug 25, 2015 $26.12949 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Aug 25, 2015 $26.12949 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Aug 25, 2015 $26.12949 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jan 21, 2015 $24.13877 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 21, 2015 $24.13877 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Dec 17, 2014 $24.11355 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
May 31, 2014 $21.47276 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
May 31, 2014 $21.47276 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
May 31, 2014 $21.47276 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Feb 19, 2014 $19.53898 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Feb 19, 2014 $19.53898 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Dec 19, 2013 $19.82051 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Dec 19, 2013 $19.82051 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Aug 27, 2013 $18.02815 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026